Letter to the Editor
Experience of using subcutaneous levetiracetam in palliative patients
Experiencia de uso de levetiracetam subcutáneo en pacientes paliativos
Read
3706
Timeswas read the article
743
Total PDF
2963
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 5 | 6 | 11 |
| 2025 11 | 216 | 116 | 332 |
| 2025 10 | 175 | 70 | 245 |
| 2025 9 | 246 | 95 | 341 |
| 2025 8 | 308 | 14 | 322 |
| 2025 7 | 330 | 24 | 354 |
| 2025 6 | 151 | 12 | 163 |
| 2025 5 | 46 | 4 | 50 |
| 2025 4 | 67 | 6 | 73 |
| 2025 3 | 52 | 9 | 61 |
| 2025 2 | 72 | 7 | 79 |
| 2025 1 | 129 | 2 | 131 |
| 2024 12 | 45 | 2 | 47 |
| 2024 11 | 53 | 10 | 63 |
| 2024 10 | 34 | 2 | 36 |
| 2024 9 | 43 | 4 | 47 |
| 2024 8 | 42 | 11 | 53 |
| 2024 7 | 34 | 3 | 37 |
| 2024 6 | 28 | 8 | 36 |
| 2024 5 | 27 | 4 | 31 |
| 2024 4 | 33 | 4 | 37 |
| 2024 3 | 26 | 3 | 29 |
| 2024 2 | 31 | 4 | 35 |
| 2024 1 | 55 | 6 | 61 |
| 2023 12 | 31 | 7 | 38 |
| 2023 11 | 29 | 13 | 42 |
| 2023 10 | 53 | 25 | 78 |
| 2023 9 | 24 | 13 | 37 |
| 2023 8 | 30 | 6 | 36 |
| 2023 7 | 24 | 6 | 30 |
| 2023 6 | 23 | 5 | 28 |
| 2023 5 | 56 | 9 | 65 |
| 2023 4 | 59 | 4 | 63 |
| 2023 3 | 13 | 3 | 16 |
| 2023 2 | 10 | 2 | 12 |
| 2023 1 | 9 | 12 | 21 |
| 2022 12 | 14 | 6 | 20 |
| 2022 11 | 19 | 15 | 34 |
| 2022 10 | 28 | 6 | 34 |
| 2022 9 | 25 | 14 | 39 |
| 2022 8 | 22 | 11 | 33 |
| 2022 7 | 12 | 8 | 20 |
| 2022 6 | 12 | 10 | 22 |
| 2022 5 | 15 | 8 | 23 |
| 2022 4 | 10 | 16 | 26 |
| 2022 3 | 16 | 12 | 28 |
| 2022 2 | 14 | 5 | 19 |
| 2022 1 | 21 | 6 | 27 |
| 2021 12 | 8 | 14 | 22 |
| 2021 11 | 24 | 13 | 37 |
| 2021 10 | 43 | 14 | 57 |
| 2021 9 | 34 | 19 | 53 |
| 2021 8 | 24 | 9 | 33 |
| 2021 7 | 13 | 11 | 24 |
| 2021 6 | 0 | 8 | 8 |
| 2021 5 | 0 | 6 | 6 |
| 2021 4 | 0 | 1 | 1 |
Show all
